about
CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphomaSplenic marginal-zone lymphoma: a distinct clinical and pathological entity.CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis.Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival.Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors.Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.CD1d-restricted peripheral T cell lymphoma in mice and humans.Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma.Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity.Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas.Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance.Cat-Scratch Disease: A Pitfall for Lymphoma Evaluation by FDG-PET/CT.CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
P50
Q28235721-02DF35E1-2B8F-40AE-9FD8-30D08A6F6298Q33346404-379DF75D-3551-44E1-8451-D5716E6B0D15Q33800449-B988702E-CA80-41A3-B638-A71C699EF5B8Q33856292-9581568F-6B67-4534-B2C0-12EBC0273371Q34543376-85D938D8-450E-4E78-83A4-83115D5B0741Q34543867-3C91B5C7-B0DE-4F0C-8C61-3BF114A443DFQ34640608-8A52AE72-630E-4297-9DBE-80E56C3969C0Q36082131-76E79194-4155-4CC3-9F2E-E1A1D3A52EA5Q36624348-3A1443C2-BCAE-4EBA-80EA-E7052C7846CAQ36863110-2BFBC3F7-65CE-4CB9-965D-277C751DEDA0Q37217181-E10A21CD-9C34-49C1-AC3F-B374670CE1D4Q37555826-8A53FA22-36AA-4320-BF1A-457C23BFDD83Q37990933-45E5CE45-977C-4B49-8500-EB485DCD061DQ38006125-E2D8D18F-D6A6-4C23-BD6F-C3D82FCAC25FQ38627352-5092FFB3-2393-4359-9DD9-C9074C137544Q39275138-EBCF1CDB-F4C0-4956-AD28-541D5766B738Q39280908-78F4EB29-BEB9-4C4D-8A07-E79A73CE7E32Q39749739-A2FF830C-8519-4787-BBC8-938E18BED32FQ40075850-11AD42A2-D6B0-46FC-ADA7-DA686BC95355Q40414752-EC256686-9E9C-46D1-A4E0-44EDC597A0D1
P50
description
onderzoeker
@nl
name
Alexandra Traverse-Glehen
@ast
Alexandra Traverse-Glehen
@en
Alexandra Traverse-Glehen
@es
type
label
Alexandra Traverse-Glehen
@ast
Alexandra Traverse-Glehen
@en
Alexandra Traverse-Glehen
@es
prefLabel
Alexandra Traverse-Glehen
@ast
Alexandra Traverse-Glehen
@en
Alexandra Traverse-Glehen
@es